Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

The Good, The Bad, and The Unexpected: Roles of DUX4 in Health and Disease.

Himeda CL, Jones PL.

Dev Cell. 2019 Sep 9;50(5):525-526. doi: 10.1016/j.devcel.2019.08.010.

PMID:
31505171
2.

The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy.

Himeda CL, Jones PL.

Annu Rev Genomics Hum Genet. 2019 Aug 31;20:265-291. doi: 10.1146/annurev-genom-083118-014933. Epub 2019 Apr 24.

PMID:
31018108
3.

Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy.

Himeda CL, Jones TI, Virbasius CM, Zhu LJ, Green MR, Jones PL.

Mol Ther. 2018 Jul 5;26(7):1797-1807. doi: 10.1016/j.ymthe.2018.04.019. Epub 2018 Apr 26.

4.

Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy.

Jones TI, Himeda CL, Perez DP, Jones PL.

Neuromuscul Disord. 2017 Mar;27(3):221-238. doi: 10.1016/j.nmd.2016.12.007. Epub 2016 Dec 23.

5.

Scalpel or Straitjacket: CRISPR/Cas9 Approaches for Muscular Dystrophies.

Himeda CL, Jones TI, Jones PL.

Trends Pharmacol Sci. 2016 Apr;37(4):249-251. doi: 10.1016/j.tips.2016.02.001. Epub 2016 Feb 22.

6.

CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy.

Himeda CL, Jones TI, Jones PL.

Mol Ther. 2016 Mar;24(3):527-35. doi: 10.1038/mt.2015.200. Epub 2015 Nov 3.

7.

Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.

Jones TI, King OD, Himeda CL, Homma S, Chen JC, Beermann ML, Yan C, Emerson CP Jr, Miller JB, Wagner KR, Jones PL.

Clin Epigenetics. 2015 Mar 29;7:37. doi: 10.1186/s13148-015-0072-6. eCollection 2015.

8.

Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease.

Himeda CL, Jones TI, Jones PL.

Antioxid Redox Signal. 2015 Jun 1;22(16):1463-82. doi: 10.1089/ars.2014.6090. Epub 2014 Dec 4. Review.

9.

Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.

Himeda CL, Debarnot C, Homma S, Beermann ML, Miller JB, Jones PL, Jones TI.

Mol Cell Biol. 2014 Jun;34(11):1942-55. doi: 10.1128/MCB.00149-14. Epub 2014 Mar 17.

10.

Pax3 synergizes with Gli2 and Zic1 in transactivating the Myf5 epaxial somite enhancer.

Himeda CL, Barro MV, Emerson CP Jr.

Dev Biol. 2013 Nov 1;383(1):7-14. doi: 10.1016/j.ydbio.2013.09.006. Epub 2013 Sep 10.

11.

Analysis of muscle gene transcription in cultured skeletal muscle cells.

Himeda CL, Tai PW, Hauschka SD.

Methods Mol Biol. 2012;798:425-43. doi: 10.1007/978-1-61779-343-1_25.

PMID:
22130852
12.

Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancer.

Tai PW, Fisher-Aylor KI, Himeda CL, Smith CL, Mackenzie AP, Helterline DL, Angello JC, Welikson RE, Wold BJ, Hauschka SD.

Skelet Muscle. 2011 Jul 7;1:25. doi: 10.1186/2044-5040-1-25.

13.

Design and testing of regulatory cassettes for optimal activity in skeletal and cardiac muscles.

Himeda CL, Chen X, Hauschka SD.

Methods Mol Biol. 2011;709:3-19. doi: 10.1007/978-1-61737-982-6_1.

PMID:
21194018
14.

KLF3 regulates muscle-specific gene expression and synergizes with serum response factor on KLF binding sites.

Himeda CL, Ranish JA, Pearson RC, Crossley M, Hauschka SD.

Mol Cell Biol. 2010 Jul;30(14):3430-43. doi: 10.1128/MCB.00302-10. Epub 2010 Apr 19.

15.

Quantitative proteomic identification of MAZ as a transcriptional regulator of muscle-specific genes in skeletal and cardiac myocytes.

Himeda CL, Ranish JA, Hauschka SD.

Mol Cell Biol. 2008 Oct;28(20):6521-35. doi: 10.1128/MCB.00306-08. Epub 2008 Aug 18.

16.

Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle.

Salva MZ, Himeda CL, Tai PW, Nishiuchi E, Gregorevic P, Allen JM, Finn EE, Nguyen QG, Blankinship MJ, Meuse L, Chamberlain JS, Hauschka SD.

Mol Ther. 2007 Feb;15(2):320-9.

17.

Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancer.

Himeda CL, Ranish JA, Angello JC, Maire P, Aebersold R, Hauschka SD.

Mol Cell Biol. 2004 Mar;24(5):2132-43.

18.

Differences in the function of three conserved E-boxes of the muscle creatine kinase gene in cultured myocytes and in transgenic mouse skeletal and cardiac muscle.

Nguyen QG, Buskin JN, Himeda CL, Shield MA, Hauschka SD.

J Biol Chem. 2003 Nov 21;278(47):46494-505. Epub 2003 Sep 10.

Supplemental Content

Loading ...
Support Center